Clinical Trial Update: Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating glyburide for malignant cerebral edema and ischemic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Cerebral Edema
• Stroke

Drugs mentioned

• Glyburide (glyburide)

Snippet

Sponsor: Remedy Pharmaceuticals, Inc. | Conditions: Ischemic Stroke, Malignant Edema | Phase 2 | Status: COMPLETED